3D Systems reported strong financial performance for Q3 2021, with revenue increasing by 14.6% year-over-year to $156.1 million. Organic revenue growth, excluding divestitures, was an impressive 35.9%. The company's transformation journey, which included restructuring and divestitures, has allowed it to focus on additive manufacturing. This focus has led to strong growth in Healthcare (28% year-over-year) and Industrial Solutions (4%). Adjusted EBITDA soared by over 125%. 3D Systems recently acquired Oqton and Volumetric Biotechnologies to expand its software capabilities and enter the regenerative medicine market. Despite supply chain challenges, the company remains optimistic about its growth prospects, supported by its strong cash position of over $500 million. The company's quarterly and annual financial performance exceeded its pre-pandemic levels.